Brought to you by 
AngioScore closes its $30mm Series D venture round
25 Sep 2020
Executive Summary
AngioScore (angioplasty catheters) has raised $30mm with its Series D venture round. Telegraph Hill Partners led the round and was joined by other new investor QuestMark Partners and current institutional backers Psilos Group Management, UV Partners, California Technology Ventures, and InnoMed Ventures. Members of Telegraph Hill Partners and QuestMark Partners joined AngioScore's board of directors.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AngioScore closes its $30mm Series D venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice